Antiplatelet drugs
Drug Safety Update
December 2014: Prasugrel (Efient▼): rare but serious hypersensitivity reactions
December 2014: Clopidogrel and proton pump inhibitors: interaction—updated advice
December 2013: Clopidogrel: risk of acquired haemophilia
- This is a very rare but serious side effect, which may be missed due to the established risk of bleeding with clopidogrel.
January 2014: Prasugrel (Efient): increased risk of bleeding- advice on timing of loading dose
October 2009: Aspirin: not licensed for primary prevention of thrombotic vascular disease
NICE Guidance (also see drug-specific links below)
NG128: Stroke and transient ischaemic attack in over 16s: diagnosis and initial management, May 2019
NG185: Acute coronary syndromes, November 2020
There is no evidence to suggest that enteric coated aspirin 75mg is safer or better tolerated than dispersible aspirin tablets.
| Pack |
|---|
| 28 tablet |
| 32 tablet |
| 100 tablet |
| 1000 tablet |
| Pack |
|---|
| 100 tablet |
| 1000 tablet |
| 16 tablet |
| 30 tablet |
| 8 tablet |
| 32 tablet |
| 500 tablet |
| Pack |
|---|
| 10 suppository |
| Pack |
|---|
| 28 tablet |
| 100 tablet |
| 16 tablet |
| 32 tablet |
| Pack |
|---|
| 56 tablet |
| 28 tablet |
| 16 tablet |
| 100 tablet |
| Pack |
|---|
| 84 tablet |
| 100 tablet |
| Pack |
|---|
| 30 capsule |
| 60 capsule |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary